Search Clinical Trials

Search results for

Migraines and the effects of the nVNS as prophylactic treatment

This study collects clinical data related to the safety and efficacy of the nVNS for the prophylactic treatment of migraine.

Migraine attacks and the effects of lasmiditan

This study will assess the efficacy, consistency of response, and safety of lasmiditan in acute treatment of 4 migraine attacks with or without aura.

PANOVA-3: Gemcitabine & Nab-Paclitaxel +/- TTFields as Front-Line Treatment for Pancreatic Cancer

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of Tumor Treating Fields (TTFields) in combination with…

Neoadjuvant Chemo with Atezolizumab or Placebo for TNBC Followed After Surgery by Atezo or Placebo

The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug,…

MIRATI 001: Study of MGCD516 in Patients with Advanced Cancer

MGCD516 is a Receptor Tyrosine Kinase (RTK) Inhibitor shown in preclinical models to inhibit a closely related spectrum of RTKs including MET, AXL, MER, and…

JAZZ 402: A Post-Marketing Observational Study of VYXEOS™

The purpose of this observational study is to provide data on the incidence and severity of infusion-related reactions during and immediately following each infusion of…

JAZZ 201: Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

This is a study comparing the Defibrotide prophylaxis arm vs standard of care arm for the prevention of aGvHD. Click here to download the Fast…

Comparing Efficacy & Safety of Polatuzumab Vedotin with R-CHP vs R-CHOP for DLBCL (POLARIX)

This Phase III, randomized, double-blind, placebo-controlled study will compare the efficacy, safety, and pharmacokinetics of Polatuzumab Vedotin plus R-CHP versus R-CHOP in participants with previously…

EISAI 222: Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib for uHCC

The primary objective of this study is to assess the safety and tolerability of subsequent Treatment of Physician's Choice (TPC) following the first-line Lenvatinib treatment…

Inotuzumab Ozogamicin & Frontline Chemo in Treating Young Adults with Newly Diagnosed B-Cell ALL

This partially randomized phase III trial studies the side effects of Inotuzumab Ozogamicin and how well it works when given with frontline chemotherapy in treating…